Wednesday Reposition: CPI Beat and NVDA's 60-Day Recovery Drive Exit From

Wednesday, July 15 — Portfolio Update

What Happened

Three developments reshaped the risk picture today, each pointing in the same direction: the AI-native compute trade is separating from both legacy technology and rate-sensitive growth in a way that strengthens the book's core positioning.

June CPI at 3.5% YoY, below consensus. Energy prices were the primary deflationary contributor — ironically during a period of elevated Iran geopolitical stress. The below-expectation read directly weakens the empirical case for Governor Waller's rate-hike signal, which had been the most acute near-term threat to the growth multiple embedded in this portfolio. The VIX declined to 16.5 from 17, and SPY added +0.36%, consistent with a modest but real risk-on re-pricing. This print does not resolve the medium-term inflation trajectory, but it reduces the probability of a near-term Fed action meaningfully.

NVDA +4.06% as IBM collapses -25%. IBM issued an earnings warning that sent shares to their worst single session on record. The street's initial interpretation might be to read this as an AI spending slowdown, but that interpretation inverts the actual evidence. IBM's miss is concentrated in consulting, hybrid-cloud managed services, and traditional IT transformation — the very revenue lines that are being disrupted by AI-native automation. CNBC's coverage noted that cybersecurity stocks rallied on IBM CEO Krishna's AI spending comments, suggesting the market correctly parsed the IBM print as a company-specific legacy IT problem, not an AI demand signal. NVDA's Blackwell accelerators are not competing with IBM's consulting division; they are what replaces it. The 60-day momentum on NVDA recovered from -2.35% (Tuesday) to +1.51% today, crossing back into positive territory and removing the monitoring flag established when it first deteriorated below zero.

JPMorgan confirmed as an AI winner. CNBC published a piece identifying JPMorgan Chase and Goldman Sachs as the financial-sector beneficiaries of AI-era trading and capital markets revenues. This is not a forward projection — it characterizes current revenue mix: proprietary AI models driving trading desk alpha, AI-assisted underwriting in capital markets, and SpaceX IPO deal flow. JPM's +2.50% session, 60-day momentum at +8.69%, and the explicit AI winner designation make it the strongest compound signal in the financials weight. Q2 earnings are the primary next catalyst.

Portfolio Changes

Exit Microsoft. MSFT's 60-day has worsened from -3.79% at entry to -5.15% today. The session was -1.55%. There is no Copilot monetization evidence, no Azure re-acceleration data, and no rate catalyst for multiple expansion — the CPI print helps the broad market but does not resolve the specific Azure margin compression from inference pricing. Pershing Square's 15.3% conviction in MSFT provides a valuation backstop, but a Q1 filing is slow-moving institutional context, not a trading signal for a name with worsening price momentum across every relevant horizon. The exit condition is clear: the 60-day deteriorated rather than recovered, and no new evidence has emerged to change the trajectory. Capital is redeployed into NVDA, JPM, and AMZN.

NVDA: 13% → 19%. The most significant position change today. Today's +4.06% session, the 60-day recovery to +1.51%, and IBM's collapse as the foil create a clean thesis confirmation: the market is pricing NVDA as the infrastructure layer of a generational compute transition, not as a cyclical chip company. The prior exit conditions — sustained 60-day below -2% combined with a credible hyperscaler order revision — are no longer active. Adding 6 percentage points brings NVDA to a weight consistent with its recovered momentum profile and structural demand signal.

JPM: 20% → 22%. A marginal increase on a strong signal day. The AI winner designation, best 60-day in the candidate universe at +8.69%, and the specific revenue thesis (trading desk AI, capital markets AI) support a modest add ahead of Q2 earnings.

LLY: 27% → 25%. A mechanical trim, not a thesis change. The 20-day softened to -1.29% and today's -2.48% session coincided with XLV falling -1.93% — classic sector rotation. No CMS ruling, no biosimilar filing, no pipeline data. The 60-day at +8.24% still leads the universe in pharma. The trim is disciplined momentum management. Primary monitoring condition: if the 20-day continues to deteriorate while XLV stabilizes, that would indicate LLY-specific weakness rather than sector rotation and would prompt a further reduction.

AMZN: 11% → 13%. A modest add from MSFT exit proceeds. The 60-day at -2.57% remains negative and limits the position size. IBM's legacy IT collapse is structurally positive for AWS cloud adoption — the enterprises compressing consulting budgets are migrating to cloud-native AI infrastructure at scale. Pershing Square's 17.4% conviction and Bridgewater's 4.1% holding provide dual institutional conviction. Q2 AWS results are the next primary catalyst.

What Major Investors Are Signaling

Pershing Square (Bill Ackman) holds AMZN at 17.4% and MSFT at 15.3% of the portfolio as of the May 2026 filing. The AMZN conviction is consistent with the position maintained here; the MSFT conviction is noted but evaluated against current momentum evidence rather than taken as a trading signal. Bridgewater Associates (Ray Dalio) holds SPY at 12.7%, IVV at 10.7%, AMZN at 4.1%, and NVDA at 3.7% — a diversified macro posture that does not translate into single-name overweights but confirms directional alignment on cloud AI infrastructure. Scion Asset Management (Michael Burry) holds NVDA at 13.5% of the portfolio as of the November 2025 filing — the most recent publicly available signal from a manager known for contrarian precision — consistent with the structural compute cycle thesis. Berkshire Hathaway's concentration in AAPL and AXP is not directly applicable but confirms the enduring value of first-party ecosystem data advantages and financial services quality, both of which inform the META and JPM thesis respectively.

What Could Break the Thesis

• LLY: An adverse CMS Medicare GLP-1 coverage ruling or a credible tirzepatide biosimilar IND filing from a well-capitalized competitor remains the primary exit signal. A third consecutive session of meaningful LLY underperformance while XLV stabilizes would warrant a further trim to 20–22% as a de-risking move.
• NVDA: A public revision of AI capex guidance from a major hyperscaler (MSFT, GOOGL, AMZN, META) pointing to reduced Blackwell orders would require position reduction. No such signal has emerged. Today's IBM miss is the opposite signal.
• JPM: A Q2 earnings miss on trading revenues or investment banking fees would weaken the AI winner thesis and prompt a trim. The risk window opens with the Q2 report.
• META: A material legal injunction blocking AI-assisted workforce optimization — not the lawsuit filing itself, which is process-level — or evidence of advertising yield compression in Q2 would be the primary thesis stressor.
• Macro: Iran re-escalation that disrupts Strait of Hormuz energy flows in a sustained way could reverse the energy deflation embedded in today's CPI print, reigniting rate-hike probability and compressing the growth multiple across the entire book. Oil's muted +0.40% session (XOM) today, despite Trump abandoning the Hormuz fee, suggests the market has partially de-risked the geopolitical tail.